Previous Article | Next Article ![]()
Journal of Clinical Microbiology, November 2000, p. 4211-4214, Vol. 38, No. 11
Laboratory of Clinical Virology, Kyushu
Research Station, National Institute of Animal Health, 2702, Chuzan, Kagoshima 891-0105, Japan
Received 31 January 2000/Returned for modification 12 May
2000/Accepted 18 August 2000
Neutralizing monoclonal antibodies (MAbs) against the Aino virus
were prepared, and the neutralizing epitopes of the virus were defined
by competitive binding assay. Seven continuous and overlapping
neutralizing epitopes existed on the G1 glycoprotein of the Aino virus.
Two antigenic domains were identified and were designated I and II,
with domain II consisting of six epitopes. Dot immunobinding assays
(DIAs) were performed with MAbs that recognized these seven
neutralizing epitopes. DIAs were performed with 1 Australian strain and
21 isolates found in Japan between the years 1964 and 1995. The MAb
response patterns of all isolates were divided into four groups. The
Japanese isolates did not show large differences in antigenicity, but
the antigenicity of the Australian strain collected in 1968 was
significantly different from that of the Japanese strains; the
Australian strain lacked reactivity to three epitopes and showed only
low reactivity to one epitope.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Comparison of Intertypic Antigenicity of Aino Virus
Isolates by Dot Immunobinding Assay Using Neutralizing Monoclonal
Antibodies
*
Corresponding author. Mailing address: Laboratory of
Epizootiology, Department of Exotic Disease, National Institute of
Animal Health, Jusuihoncho 6-20-1, Kodaira, Tokyo, 187-0022, Japan.
Phone: 81-42-321-1441. Fax: 81-42-325-5122. E-mail:
yoshidak{at}ed.affrc.go.jp.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»